Two recent studies have shown that lenalidomide in combination with high-dose dexamethasone is significantly more effective than high-dose dexamethasone alone in patients with relapsed multiple myeloma.
Related Articles
Senza categoria
Newsround
Senza categoria
NEWSROUND
Impact Factor
Leave a Reply